Search Results - "TALOS, Flaminia"

Refine Results
  1. 1

    Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells by Li, Dun, Marchenko, Natalia D, Schulz, Ramona, Fischer, Victoria, Velasco-Hernandez, Talia, Talos, Flaminia, Moll, Ute M

    Published in Molecular cancer research (01-05-2011)
    “…The tight control of wild-type p53 by mainly MDM2 in normal cells is permanently lost in tumors harboring mutant p53, which exhibit dramatic constitutive p53…”
    Get full text
    Journal Article
  2. 2

    A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue by Talos, Flaminia, Mitrofanova, Antonina, Bergren, Sarah K., Califano, Andrea, Shen, Michael M.

    Published in Nature communications (21-04-2017)
    “…To date, reprogramming strategies for generating cell types of interest have been facilitated by detailed understanding of relevant developmental regulatory…”
    Get full text
    Journal Article
  3. 3

    Cortical hypoplasia and ventriculomegaly of p73-deficient mice: Developmental and adult analysis by Medina-Bolívar, Carolina, González-Arnay, Emilio, Talos, Flaminia, González-Gómez, Miriam, Moll, Ute M., Meyer, Gundela

    Published in Journal of comparative neurology (1911) (01-08-2014)
    “…ABSTRACT Trp73, a member of the p53 gene family, plays a crucial role in neural development. We describe two main phenotypic variants of p73 deficiency in the…”
    Get full text
    Journal Article
  4. 4

    Mitochondrially targeted p53 has tumor suppressor activities in vivo by TALOS, Flaminia, PETRENKO, Oleksi, MENA, Patricio, MOLL, Ute M

    Published in Cancer research (Chicago, Ill.) (01-11-2005)
    “…Complex proapoptotic functions are essential for the tumor suppressor activity of p53. We recently described a novel transcription-independent mechanism that…”
    Get full text
    Journal Article
  5. 5

    While p73 is essential, p63 is completely dispensable for the development of the central nervous system by Holembowski, Lena, Schulz, Ramona, Talos, Flaminia, Scheel, Andreas, Wolff, Sonja, Dobbelstein, Matthias, Moll, Ute

    Published in Cell cycle (Georgetown, Tex.) (15-02-2011)
    “…The ancient p53 paralogs p63 and p73 regulate specific tissue formation, cell survival and cell death via their TA and ΔN isoforms. Targeted disruption of the…”
    Get full text
    Journal Article
  6. 6

    Role of the p53 family in stabilizing the genome and preventing polyploidization by Talos, Flaminia, Moll, Ute M

    “…Cellular defects resulting in chromosomal instability and aneuploidy are the most common features of human cancers. As a major tumor suppressor and intrinsic…”
    Get more information
    Journal Article
  7. 7

    E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression by Palacios, Gustavo, Talos, Flaminia, Nemajerova, Alice, Moll, Ute M, Petrenko, Oleksi

    Published in Cell cycle (Georgetown, Tex.) (15-06-2008)
    “…To better understand the role of E2F1 in tumor formation, we analyzed spontaneous tumorigenesis in p53-/-E2F1+/+ and p53-/-E2F1-/- mice. We show that the…”
    Get full text
    Journal Article
  8. 8

    ECMarker: interpretable machine learning model identifies gene expression biomarkers predicting clinical outcomes and reveals molecular mechanisms of human disease in early stages by Jin, Ting, Nguyen, Nam D, Talos, Flaminia, Wang, Daifeng

    Published in Bioinformatics (23-05-2021)
    “…Abstract Motivation Gene expression and regulation, a key molecular mechanism driving human disease development, remains elusive, especially at early stages…”
    Get full text
    Journal Article
  9. 9

    Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks by Chen, James C., Alvarez, Mariano J., Talos, Flaminia, Dhruv, Harshil, Rieckhof, Gabrielle E., Iyer, Archana, Diefes, Kristin L., Aldape, Kenneth, Berens, Michael, Shen, Michael M., Califano, Andrea

    Published in Cell (09-10-2014)
    “…Identification of driver mutations in human diseases is often limited by cohort size and availability of appropriate statistical models. We propose a framework…”
    Get full text
    Journal Article
  10. 10

    Abstract 3126: Intratumor heterogeneity and clonal dynamics underlying treatment resistance in prostate cancer by Tshering, Lara F, Luo, Fu, Nguyen, Nam D., Rail, James G., Jin, Ting, Wang, Daifeng, Talos, Flaminia

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Prostate cancer (PCa) is one of the most common cancers in men worldwide and a leading cause of cancer-related mortality. Though PCa is known to be…”
    Get full text
    Journal Article
  11. 11

    Abstract 3076: Clonal dynamics and single cell transcriptomics of prostate luminal epithelial cells in aging and cancer by Luo, Fu, Tshering, Lara F., Tutuska, Karis, Szenk, Mariola, Rubel, Diana, Rail, James, Russ, Savanah, Balázsi, Gábor, Talos, Flaminia

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Age-related prostate diseases are among the most frequently encountered conditions in the male population and age remains a major risk for prostate cancer…”
    Get full text
    Journal Article
  12. 12

    Immune mechanisms shape the clonal landscape during early progression of prostate cancer by Tshering, Lara F., Luo, Fu, Russ, Savanah, Szenk, Mariola, Rubel, Diana, Tutuska, Karis, Rail, James G., Balázsi, Gábor, Shen, Michael M., Talos, Flaminia

    Published in Developmental cell (19-06-2023)
    “…Understanding the role of the immune microenvironment in modulating intratumor heterogeneity is essential for effective cancer therapies. Using multicolor…”
    Get full text
    Journal Article
  13. 13

    Abstract A085: A luminal intermediate cell state maintains long-term prostate homeostasis and contributes to tumorigenesis by Luo, Fu, Tshering, Lara F., Tutuska, Karis, Szenk, Mariola, Rubel, Diana, Rail, James G., Russ, Savanah, Liu, Jingxuan, Nemajerova, Alice, Balázsi, Gábor, Talos, Flaminia

    Published in Cancer research (Chicago, Ill.) (02-06-2023)
    “…Cellular heterogeneity poses tremendous challenges for developing cell-targeted therapies and biomarkers of clinically significant prostate cancer. The origins…”
    Get full text
    Journal Article
  14. 14

    Epithelial cell lineage specification during prostate organogenesis and regeneration (210.4) by Shen, Michael, Wang, Zhu, Shibata, Maho, Talos, Flaminia, Chua, Chee Wai, Lei, Ming, Bergren, Sarah

    Published in The FASEB journal (01-04-2014)
    “…The prostate gland is a particularly interesting system for the investigation of cell lineage specification given the central role of androgen signaling in all…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    p63 and canonical Wnt signaling by Talos, Flaminia, Schulz, Ramona, Moll, Ute

    Published in Cell cycle (Georgetown, Tex.) (15-02-2010)
    “…Comment on: Drewelus I, et al. Cell Cycle 2010; 9(3); In press…”
    Get full text
    Journal Article
  18. 18

    p73 Suppresses Polyploidy and Aneuploidy in the Absence of Functional p53 by Talos, Flaminia, Nemajerova, Alice, Flores, Elsa R., Petrenko, Oleksi, Moll, Ute M.

    Published in Molecular cell (17-08-2007)
    “…Previous studies showed that p53 plays a central role in G1 and DNA damage checkpoints, thus contributing to genomic stability. We show here that p73 also…”
    Get full text
    Journal Article
  19. 19

    The alpha/beta carboxyterminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins by Wolff, Sonja, Talos, Flaminia, Palacios, Gustavo, Beyer, Ulrike, Dobbelstein, Matthias, Moll, Ute M.

    Published in Cell death and differentiation (20-03-2009)
    “…p63, an ancestral transcription factor of the p53 family, has three C-terminal isoforms whose relative in vivo functions are elusive. The p63 gene is essential…”
    Get full text
    Journal Article
  20. 20